Analysts expect more upside in the run up to August rebalance of MSCI index weightage
The gains come amid the background of strong economic data and optimism around the functioning of the new government
Sustained foreign helps indices log best day in over than two weeks
Sun Pharmaceutical Industries on Friday said it has inked a licensing pact with Takeda Pharmaceutical Company to commercialise a novel gastrointestinal drug in India. The company has entered into a non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan tablets in strengths of 10 and 20 mg in India, the Mumbai-based drug major said in a statement. Vonoprazan is a novel, orally active potassium competitive acid blocker (PCAB), used to treat reflux esophagitis and other acid peptic disorders. "Sun Pharma is a leader in gastroenterology and we are excited to introduce Vonoprazan in India under non-exclusive patent license from Takeda," Sun Pharma CEO - India Business Kirti Ganorkar said. The partnership demonstrates the company's commitment to gastrointestinal health by providing patients and healthcare practitioners with a novel treatment option to manage reflux esophagitis and other acid peptic disorders, he added. Gastroesophageal Reflux Disease (GERD) is
The new rules could include higher margins for options contracts and more detailed disclosures
The mutual fund (MF) industry is concerned that the upcoming Union Budget may bring another tax blow
Sensex, Nifty jump over 3% each; investor wealth surges Rs 14 trn; FPIs pump in Rs 6.9K cr
Public-sector undertaking (PSU) banks were among biggest gainers on Monday, leading to a 8.4 per cent rise in the Nifty PSU Bank index, a index of only government-owned lenders
However, in case, the BSE Sensex is unable to break past the 76,275 level, we may enter a consolidation range, wherein the support at 72,240 becomes a crucial level.
Emkay Investment Managers predict Nifty to reach 26,500 by 2025, citing factors like 15% earnings growth, positive election outcome & sectoral focus on BFSI, PSUs, and green energy
With barely a fortnight remaining for the outcome of the Lok Sabha polls, markets seem to be a bit nervous. Puneet Wadhwa caught up with RAHUL ARORA, CEO for Institutional Equities at Nirmal Bang
The rupee was trading in a narrow range and appreciated 4 paise to 83.47 against the US dollar in early trade on Wednesday, tracking a positive trend in domestic equities. However, sustained foreign fund outflows weighed on the local unit and restricted the up move. Forex traders said with foreign investors buying US dollars and the Reserve Bank of India (RBI) selling the greenback, the USD/INR pair is expected to remain range-bound with a bit of a weakness bias. At the interbank foreign exchange market the local unit moved in a narrow range. It opened at 83.49 against the American currency and touched 83.47 in initial trade, registering a rise of 4 paise from its previous close. On Tuesday, the rupee closed at 83.51 against the American currency. Meanwhile, the dollar index, which gauges the greenback's strength against a basket of six currencies, was at 104.93, lower by 0.07 per cent. Brent crude futures, the global oil benchmark, rose 0.69 per cent to USD 82.95 per barrel. Des
The index finished below its 100-day moving average (DMA), seen as a critical support, for the first time since November 13, 2023
The last time this happened was on March 31, 2017, when Nifty closed at 9,173.75
According to industry players, one of the key requirements for approving NSE's IPO is for it to remain free from any tech-glitch for a year
The grey market premiums (GMPs) for the three initial public offerings (IPOs) that open this week range between 20 per cent and 55 per cent
Sensex sees intraday swing of 1,627 points
The NSE benchmark Nifty is likely to reach the 25,800 level by December 2024 as stable economic policies and normal monsoon will boost demand growth, Prabhudas Lilladher said in a report on Thursday. The index is currently trading at 22,570.35 level. Going by the prediction of Prabhudas Lilladher, the Nifty is expected to climb another 3,239.65 points or 14.35 per cent from its current level by December-end this year. "Recently, the Nifty reached its all-time peak, but subsequently experienced a correction of around 4 per cent attributed to escalating geopolitical tensions, fluctuations in crude oil and commodity prices, and differing perspectives on the anticipated interest rate adjustments by the US Federal Reserve," Amnish Aggarwal, Head of Institutional Research, Prabhudas Lilladher, said. The Nifty is expected to scale up to 25,810 levels by December 2024, Aggarwal added. "The upward mobility in Nifty is attributed to the continuation of the NDA government and La Nina led norm
Nifty gains 0.9% even as FPI selling continues
The indices closed in the red after volatile trade